PureTech Health plc (LON:PRTC)

PureTech Health Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	121.28	252.47	280.64	191.08	149.87	465.71
Short-Term Investments	110.24	36.25	98.05	136.06	200.23	-
Cash & Short-Term Investments	231.52	288.72	378.69	327.14	350.1	465.71
Cash Growth	-30.11%	-23.76%	15.76%	-6.56%	-24.82%	15.31%
Accounts Receivable	2.14	1.76	1.52	2.38	12.32	3.59
Other Receivables	6.39	6.37	-	11.75	10.04	4.51
Receivables	8.53	8.13	1.52	14.12	22.36	23.22
Prepaid Expenses	1.82	6.58	4.4	4.31	11.62	10.76
Restricted Cash	-	1.6	1.64	1.63	2.12	2.12
Other Current Assets	10.46	-	-	-0	-0	-0
Total Current Assets	252.32	305.02	386.26	347.2	386.19	501.81
Property, Plant & Equipment	9.85	11.5	15.13	19.36	37.24	43.94
Long-Term Investments	374.9	217.43	200.17	325.63	277.54	397.18
Other Intangible Assets	0.2	0.6	0.6	0.91	0.83	0.99
Long-Term Accounts Receivable	-	-	-	-	0.84	1.29
Other Long-Term Assets	0	0.17	0.48	0.88	0.01	0.81
Total Assets	637.28	534.71	602.64	693.97	702.65	946.01

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	7.43	3.07	5.52	14.64	26.5	11.35
Accrued Expenses	19.65	20.1	20.58	29.47	26.32	22.01
Short-Term Debt	5.38	4.92	4.11	3.7	2.35	4.64
Current Portion of Long-Term Debt	17.16	13.25	6.44	-	5.16	0.86
Current Portion of Leases	3.77	3.58	3.58	3.39	4.97	3.95
Current Income Taxes Payable	1.29	1.21	0.08	-	0.06	0.06
Current Unearned Revenue	-	-	-	-	2.19	0.07
Other Current Liabilities	0.18	0.18	1.09	0.17	29.34	183.21
Total Current Liabilities	54.86	46.31	41.39	51.37	96.89	226.14
Long-Term Debt	187.26	170.42	136.78	110.16	10.24	14.26
Long-Term Leases	9.16	11.09	14.67	18.25	24.16	29.04
Long-Term Deferred Tax Liabilities	6	-	-	52.46	19.65	89.77
Other Long-Term Liabilities	0.51	1.22	1.86	3.5	4.13	2.66
Total Liabilities	257.79	229.03	194.7	235.74	155.06	361.86

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4.86	4.86	4.86	5.46	5.46	5.44
Additional Paid-In Capital	290.26	290.26	290.26	290.26	289.62	289.3
Retained Earnings	-9.98	-77.23	32.49	83.82	149.52	199.87
Treasury Stock	-36.78	-41.15	-46.86	-44.63	-26.49	-
Comprehensive Income & Other	137.87	135.34	133.96	129.15	124.12	98.9
Total Common Equity	386.23	312.07	414.71	464.07	542.22	593.52
Minority Interest	-6.74	-6.4	-6.77	-5.84	5.37	-9.37
Shareholders' Equity	379.49	305.68	407.93	458.23	547.59	584.15
Total Liabilities & Equity	637.28	534.71	602.64	693.97	702.65	946.01

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	222.73	203.26	165.58	135.5	46.87	52.75
Net Cash (Debt)	8.79	85.46	213.11	191.64	303.22	412.96
Net Cash Growth	-94.76%	-59.90%	11.20%	-36.80%	-26.57%	26.19%
Net Cash Per Share	0.04	0.35	0.84	0.69	1.06	1.44
Filing Date Shares Outstanding	243.42	243.42	240.19	270.21	278.46	287.84
Total Common Shares Outstanding	243.42	241.68	239.42	271.85	278.57	287.8
Working Capital	197.46	258.71	344.87	295.83	289.31	275.67
Book Value Per Share	1.59	1.29	1.73	1.71	1.95	2.06
Tangible Book Value	386.03	311.47	414.11	463.16	541.39	592.53
Tangible Book Value Per Share	1.59	1.29	1.73	1.70	1.94	2.06
Machinery	-	3.18	4.75	7.35	16.27	14.51
Construction In Progress	-	-	-	0	2.8	8.12
Leasehold Improvements	-	15.17	15.17	15.17	23.96	18.49

Data Source: S&P Global Market Intelligence Last updated: Sep 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 25, 2026

Data Sources Report a data error